首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan.
【24h】

Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan.

机译:台湾中部多重耐药的鲍曼不动杆菌中的抗生素抗性和OXA碳青霉烯酶基因的流行率。

获取原文
获取原文并翻译 | 示例
           

摘要

This study analyzed the prevalence of antibiotics resistance and the distribution of genes responsible for carbapenems resistance in Acinetobacter baumannii isolates. Clinical A. baumannii isolates were cultured, identified, and collected during the period from May 2007 to February 2009. Antibiotics resistance rates of the clinical isolates were analyzed by antimicrobial susceptibility testing. The distribution of carbapenemase alleles were investigated in the multidrug-resistant (MDR) A. baumannii isolates by multiplex polymerase chain reaction (PCR) techniques. A total of 1,265 independent A. baumannii isolates were identified. Approximately 70% of the clinical isolates were resistant to ampicillin/sulbactam, followed by imipenem, meropenem, cefepime, piperacillin/tazobactam, ceftazidime, and cefoperazone. Overall, 15.18% (192/1,265) of the isolates were characterized as MDR strains. All of the MDR A. baumannii isolates carried the bla (OXA51-like) allele. The detection rate of the bla (OXA23-like) and bla (OXA24-like) alleles was 96.35% (185/192) and 0.52% (1/192), respectively. Most of the isolates (185/192, 96.35%) carried genes which encode more than one carbapenemase. This report demonstrated that approximately 15% of A. baumannii clinical isolates in central Taiwan are MDR strains, with most of them harboring multiple carbapenemases. This study provides updated data regarding the prevalence of beta-lactam resistance and genotyping information of carbapenems resistance of A. baumannii in central Taiwan.
机译:这项研究分析了鲍曼不动杆菌分离物中抗生素耐药性的流行情况以及负责碳青霉烯类耐药的基因的分布。在2007年5月至2009年2月期间培养,鉴定和收集了鲍曼不动杆菌临床分离株。通过抗菌药敏试验分析了临床分离株的抗生素耐药率。通过多重聚合酶链反应(PCR)技术研究了耐多药(MDR)鲍曼不动杆菌中碳青霉烯酶等位基因的分布。总共鉴定了1,265个独立的鲍曼不动杆菌。约70%的临床分离株对氨苄西林/舒巴坦耐药,其次是亚胺培南,美罗培南,头孢吡肟,哌拉西林/他唑巴坦,头孢他啶和头孢哌酮。总体上,分离株的15.18%(192 / 1,265)被鉴定为MDR菌株。所有的MDR鲍曼不动杆菌分离株均带有bla(OXA51样)等位基因。 bla(OXA23-like)和bla(OXA24-like)等位基因的检出率分别为96.35%(185/192)和0.52%(1/192)。大多数分离株(185 / 192,96.35%)携带的基因编码一种以上的碳青霉烯酶。该报告表明,台湾中部大约有15%的鲍曼不动杆菌临床分离株是MDR菌株,其中大多数带有多种碳青霉烯酶。这项研究提供了台湾中部鲍曼不动杆菌对β-内酰胺耐药性的流行情况和碳青霉烯类耐药性的基因分型信息。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号